A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase

Manning Donald C.; Gimbel Joseph; Wertz Robert; Rauck Richard; Cooper Alyse; Zeldis Jerome B.; Levinsky Dale M.

首页> 外文期刊>Pain medicine : >A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase

【24h】

A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase

机译：Lenalal族疼痛中Lenalidomide在Lenalal突出疼痛中的一期随机，双盲，安慰剂控制的安全性和疗效研究A II期随机，双盲，安慰剂对照安全性和Lenalidomide的疗效研究在腰部疼痛的长期开放标签扩展阶段

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. This phase II study assessed lenalidomide efficacy and safety.

机译：客观的。该II期研究评估了Lenalidomide疗效和安全性。

著录项

来源
《Pain medicine :》 |2017年第3期|共11页
作者
Manning Donald C.; Gimbel Joseph; Wertz Robert; Rauck Richard; Cooper Alyse; Zeldis Jerome B.; Levinsky Dale M.;
展开▼
作者单位

Adynxx Inc San Francisco CA USA;

Arizona Res Ctr Phoenix AZ USA;

Lehigh Valley Hosp Ctr Pain Management Allentown PA USA;

PA &

Ctr Clin Res LLC Carolinas Pain Inst Winston Salem NC USA;

Celgene Corp Clin Res Summit NJ USA;

Celgene Corp Clin Res Summit NJ USA;

Family Practice Tucson AZ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类症状诊断学;
关键词
Lumbar Radicular Pain; Chronic Pain; Neuropathic Pain; Lenalidomide; Inflammation;

机译：腰部自然疼痛;慢性疼痛;神经性疼痛;Lenalidomide;炎症;

相似文献

外文文献
中文文献

1. A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase [J] . Manning Donald C., Gimbel Joseph, Wertz Robert, Pain medicine : . 2017,第3期

机译：Lenalal族疼痛中Lenalidomide在Lenalal突出疼痛中的一期随机，双盲，安慰剂控制的安全性和疗效研究A II期随机，双盲，安慰剂对照安全性和Lenalidomide的疗效研究在腰部疼痛的长期开放标签扩展阶段
2. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. [J] . Kress HG, Oronska A, Kaczmarek Z Clinical therapeutics . 2009,第6期

机译：鼻内芬太尼喷雾剂50至200微克对癌症患者的突破性疼痛的疗效和耐受性：一项III期，跨国，随机，双盲，安慰剂对照，交叉试验，为期10个月，开放标签延长治疗期。
3. Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: A randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase [J] . KakuK., MoriM., KanooT., Expert opinion on pharmacotherapy . 2014,第15期

机译：在日本2型糖尿病患者中向胰岛素添加阿格列汀的疗效和安全性：一项随机，双盲，为期12周的安慰剂对照试验，随后进行了开放标签的长期延长研究
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Long-term efficacy safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre randomised double-blind parallel-group study [O] . Min-Chan Park, Hiroaki Matsuno, Jinseok Kim, 2019

机译：使用依那西普生物仿制药（LBEC0101）或从参考依那西普转为LBEC0101的类风湿关节炎患者的长期疗效安全性和免疫原性：III期多中心随机双盲平行分组研究的开放标签扩展
7. A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase [O] . Donald C. Manning, Joseph Gimbel, Robert Wertz, 2016

机译：具有长期开放标签延伸阶段的腰部自由疼痛中Lenalidomide的II期随机，双盲，安慰剂控制的安全性和疗效研究

摘要

著录项

相似文献

相关主题

期刊订阅